GW&K Investment Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1082917
BOSTON, MA
Position in LGND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$78,037,246
+$48,189,372 QoQ
Shares Held
246,883
+65.1% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#24
of 413 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 96%
Shared 4%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $876,997,841 across 27 Biotechnology names. LGND ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
1,353,883 | $105,968,422 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
350,667 | $84,500,226 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,125,131 | $83,799,756 | |
| 4 | CYTK |
Cytokinetics Inc
|
916,107 | $78,043,155 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
This page
|
246,883 | $78,037,246 | |
| 6 | VCEL |
Vericel Corp
|
1,550,497 | $68,981,610 | |
| 7 | INSM |
INSMED Inc
|
629,760 | $67,145,010 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,731,140 | $64,779,258 |
All Filings in LGND
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,037,246 | 246,883 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $29,847,874 | 149,501 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $22,202,867 | 117,432 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,692,393 | 32,135 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,800,436 | 33,431 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,664,970 | 34,858 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,769,965 | 35,184 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,779,498 | 37,761 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,287,656 | 39,018 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,906,821 | 39,765 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,952,025 | 55,335 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,242,805 | 37,430 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,747,586 | 38,108 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,858,394 | 38,858 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $2,010,279 | 30,094 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,618,087 | 30,404 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,003,142 | 33,660 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,922,865 | 34,873 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $3,940,273 | 25,510 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||